I&I Bio: Investment Portfolio & Startup News

AI Search

Announce News

I&I Bio

To add a bio or update investment portfolio click update information.

Investment Portfolio

Ternary Therapeutics

16 Mar 2026

Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

Ternary Therapeutics develops computational and laboratory tools to design molecular glue medicines. Its platform predicts how proteins interact and suggests molecules that can bring them together, helping researchers target disease-driving proteins previously considered undruggable.

I&I Bio

- Life Sciences
1(12 months)
inibio.eu
Update Information

More venture news

Cori Clinical
7 Oct 2026
Cori Clinical unlocks a £3m seed round led by Breega for an AI workspace improving clinical trial design
SeedLife Sciences
PlannerPal
7 Oct 2026
PlannerPal lands a £4.3m seed round led by Mercia Ventures to deliver client intelligence to UK financial advice firms
SeedFintech
Nettle
6 Oct 2026
Nettle lands a £3.6m seed round led by MTech to help insurers inspect commercial risks five times faster
SeedFintech

I&I Bio: Investment Portfolio & Startup News

Investment Portfolio

Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

More venture news

Cori Clinical unlocks a £3m seed round led by Breega for an AI workspace improving clinical trial design

PlannerPal lands a £4.3m seed round led by Mercia Ventures to deliver client intelligence to UK financial advice firms

Nettle lands a £3.6m seed round led by MTech to help insurers inspect commercial risks five times faster